rs7904519

This is a intron variant variant in the TCF7L2 gene.

GWAS Catalog Trait Associations (4)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

breast carcinoma

Michailidou K et al. Association analysis identifies 65 new breast cancer risk loci. Nature 551(7678):92-94 (2017)
Allele G
OR 1.03
p 2.0e-13
N 139,274
Large GWAS
multi-ancestry
Allele G
OR 0.96
p 2.0e-13
N 277,932
Large GWAS
multi-ancestry
Allele G
OR 1.05
p 9.0e-13
N 33,832
Large GWAS
European
Michailidou K et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nature Genetics 45(4):353-61, 361e1-2 (2013)
Allele G
OR 1.06
p 3.0e-8
N 22,627
Large GWAS
European

promotilin measurement

Allele G
OR 0.03
p 3.0e-12
N 47,745
Large GWAS
European

estrogen-receptor negative breast cancer

Allele G
OR 1.08
p 8.0e-10
N 72,261
Large GWAS
European

thoracic aortic aneurysm

Roychowdhury T et al. Regulatory variants in TCF7L2 are associated with thoracic aortic aneurysm. American Journal of Human Genetics 108(9):1578-1589 (2021)
Allele G
OR 0.09
p 3.0e-9
N 19,646
Large GWAS
European

ClinVar annotation

Benign☆☆☆
1 submitter
View on ClinVar →

About TCF7L2

This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010]

View all TCF7L2 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…